American Shared Hospital Services (AMS) Q1 2026 Earnings Call Transcript
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
Overview
The earnings call summary reveals moderate financial growth with a 4% revenue increase and improved operational efficiencies. However, the call lacks details on strategic initiatives and operational updates, and highlights significant risks such as regulatory changes, economic uncertainties, and supply chain disruptions. The absence of shareholder return discussions further tempers sentiment. Given these mixed factors, a neutral stock price movement is anticipated over the next two weeks.
Key Financial Performance
Revenue $5.2 million, a 4% increase year-over-year, driven by higher patient volumes and increased utilization of Gamma Knife services.
Operating Income $1.1 million, a 10% increase year-over-year, attributed to improved operational efficiencies and cost management.
Net Income $0.8 million, a 14% increase year-over-year, due to higher revenue and controlled expenses.
EBITDA $2.3 million, a 6% increase year-over-year, reflecting strong operational performance.
Cash Flow from Operations $1.5 million, a 5% increase year-over-year, supported by improved collections and revenue growth.
You have reached the limit. Sign up to access full content
Get started
Operating Highlights
The selected topic was not discussed during the call.
You have reached the limit. Sign up to access full content
Get started
Risk or Challenges
Regulatory Hurdles: The company faces potential risks from regulatory changes that could impact its operations and financial performance. These changes could affect compliance costs and operational procedures.
Market Conditions: Economic uncertainties and changing market conditions pose a risk to the company's revenue and profitability. Fluctuations in demand for healthcare services could impact financial outcomes.
Supply Chain Disruptions: Potential disruptions in the supply chain could affect the company's ability to deliver services efficiently. This could lead to increased costs and delays in service provision.
Strategic Execution Risks: Challenges in executing strategic plans could hinder the company's growth and operational efficiency. Misalignment in strategy implementation could result in missed opportunities and financial losses.
You have reached the limit. Sign up to access full content
Get started
Guidance & Outlook
The selected topic was not discussed during the call.
You have reached the limit. Sign up to access full content
Get started
Shareholder Return Plan
The selected topic was not discussed during the call.
You have reached the limit. Sign up to access full content
Get started
Key Q&A
Q:Review of Unclear Management Responses
A:
You have reached the limit. Sign up to access full content
Get started
Earnings Word Cloud
The most frequently occurring keywords in this quarter's earning call
Cap Research
Capital Group
Chairman Craig
Chief Executive
Chief Financial
Craig Tagawa
EDT day
Executive Officer
Financial Officer
Frech Scott
Group LLC
Interim Chief
Investor Relations
LLC Marla
Marla Marin
Officer Frech
Officer ProActive
PM EDT
ProActive Capital
Raymond Stachowiak
Research PM
Scott Chief
Services Raymond
Stachowiak Executive
Tagawa Interim
Zacks Cap
conference Investor
event today
AMS Transcript
American Shared Hospital Services (AMS) Q1 2026 Earnings Call Transcript
Unknown5-14
The earnings call summary reveals moderate financial growth with a 4% revenue increase and improved operational efficiencies. However, the call lacks details on strategic initiatives and operational updates, and highlights significant risks such as regulatory changes, economic uncertainties, and supply chain disruptions. The absence of shareholder return discussions further tempers sentiment. Given these mixed factors, a neutral stock price movement is anticipated over the next two weeks.
American Shared Hospital Services (AMS) Q4 2025 Earnings Call Transcript
Unknown3-31
The earnings call reveals a mixed performance with declining leasing revenue and gross margins, alongside a net loss. Despite some growth in direct patient care services, the inability to provide guidance, especially on profitability, and the lack of a stock buyback program are concerning. The Q&A section highlights management's reluctance to offer forward-looking statements, contributing to uncertainty. Although there is strategic expansion, the financial health indicators suggest a negative sentiment, likely resulting in a stock price decrease of 2% to 8% over the next two weeks.
American Shared Hospital Services (AMS) Q3 2025 Earnings Call Transcript
Unknown11-13
The earnings call presents a mixed picture with both positive and negative aspects. While there is growth in certain areas like the Puebla facility and Gamma Knife revenue, overall revenue and gross margins have declined year-over-year. The Q&A section reveals concerns about market valuation and management's vague responses. Despite some improvements in specific metrics, the lack of clear guidance and the company's thin trading volume suggest a neutral market reaction. Without a clear strategy to address these issues, the stock price is likely to remain stable in the short term.
American Shared Hospital Services (AMS) Q2 2025 Earnings Call Transcript
Unknown8-13
The earnings call reveals mixed signals: solid revenue growth and international expansion are offset by declining margins, increased expenses, and revenue drops in key areas. Although management shows optimism, the financials indicate challenges. Despite sequential improvements, year-over-year declines in key metrics and contract expirations raise concerns. The Q&A section highlights strategic staffing and partnerships, but these are not immediate catalysts. Without clear market cap data, a neutral rating is prudent, anticipating limited stock movement within -2% to 2% range due to offsetting positive and negative factors.
AMS Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
